Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population

Authors: Bancha Satirapoj, Pokkrong Limwannata, Amnart Chaiprasert, Ouppatham Supasyndh, Panbuppa Choovichian

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Vitamin D insufficiency is associated with proteinuria and could be a risk factor for end-stage renal disease (ESRD). However, few studies have examined the significance of vitamin D insufficiency as a contributing factor for the development of ESRD in the Asian chronic kidney disease (CKD) population.

Methods

Authors examined the relationship between vitamin D status and the staging of CKD using data from an outpatient clinic-based screening in 2,895 Thai CKD patients. Serum levels of 25-hydroxyvitamin D were analyzed according to CKD stages. Vitamin D deficiency and insufficiency were defined as a serum 25-hydroxyvitamin D concentration < 10 ng/mL and 10–30 ng/mL, respectively.

Results

The mean (SD) 25-hydroxyvitamin D levels were significantly lower according to severity of renal impairment (CKD stage 3a: 27.84±14.03 ng/mL, CKD stage 3b: 25.86±11.14 ng/mL, CKD stage 4: 24.09±11.65 and CKD stage 5: 20.82±9.86 ng/mL, p<0.001). The prevalence of vitamin D deficiency/insufficiency was from CKD stage 3a, 3b, 4 to 5, 66.6%, 70.9%, 74.6%, and 84.7% (p<0.001). The odds ratio (95% CI) of vitamin D insufficiency/deficiency (serum 25-hydroxyvitamin D ≤ 30 ng/mL) and vitamin D deficiency (serum 25-hydroxyvitamin D < 10 ng/mL) for developing ESRD, after adjustment for age, gender, hemoglobin, serum albumin, calcium, phosphate and alkaline phosphatase were 2.19 (95% CI 1.07 to 4.48) and 16.76 (95% CI 4.89 to 57.49), respectively.

Conclusion

This study demonstrates that 25-hydroxyvitamin D insufficiency and deficiency are more common and associated with the level of kidney function in the Thai CKD population especially advanced stage of CKD.
Appendix
Available only for authorised users
Literature
1.
go back to reference Diniz HF, Romao MF, Elias RM, Romao Junior JE: Vitamin D deficiency and insufficiency in patients with chronic kidney disease. J Bras Nefrol. 2012, 34: 58-63. 10.1590/S0101-28002012000100009.CrossRefPubMed Diniz HF, Romao MF, Elias RM, Romao Junior JE: Vitamin D deficiency and insufficiency in patients with chronic kidney disease. J Bras Nefrol. 2012, 34: 58-63. 10.1590/S0101-28002012000100009.CrossRefPubMed
2.
go back to reference Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med. 1998, 338: 777-783. 10.1056/NEJM199803193381201.CrossRefPubMed Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS: Hypovitaminosis D in medical inpatients. N Engl J Med. 1998, 338: 777-783. 10.1056/NEJM199803193381201.CrossRefPubMed
3.
go back to reference Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009, 75: 88-95. 10.1038/ki.2008.501.CrossRefPubMed Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009, 75: 88-95. 10.1038/ki.2008.501.CrossRefPubMed
4.
go back to reference Mailliez S, Shahapuni I, Lecaque C, Massy ZA, Choukroun G, Fournier A: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2008, 74: 389-author reply 389CrossRefPubMed Mailliez S, Shahapuni I, Lecaque C, Massy ZA, Choukroun G, Fournier A: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2008, 74: 389-author reply 389CrossRefPubMed
5.
go back to reference Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007, 71: 31-38. 10.1038/sj.ki.5002009.CrossRefPubMed Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL: Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007, 71: 31-38. 10.1038/sj.ki.5002009.CrossRefPubMed
6.
go back to reference Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007, 72: 1004-1013. 10.1038/sj.ki.5002451.CrossRefPubMed Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. 2007, 72: 1004-1013. 10.1038/sj.ki.5002451.CrossRefPubMed
7.
go back to reference Chonchol M, Scragg R: 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007, 71: 134-139. 10.1038/sj.ki.5002002.CrossRefPubMed Chonchol M, Scragg R: 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int. 2007, 71: 134-139. 10.1038/sj.ki.5002002.CrossRefPubMed
8.
go back to reference Park S, Lee BK: Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged >/= 50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract. 2012, 6: 162-168. 10.4162/nrp.2012.6.2.162.CrossRefPubMedPubMedCentral Park S, Lee BK: Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged >/= 50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract. 2012, 6: 162-168. 10.4162/nrp.2012.6.2.162.CrossRefPubMedPubMedCentral
9.
go back to reference Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008, 168: 1174-1180. 10.1001/archinte.168.11.1174.CrossRefPubMedPubMedCentral Giovannucci E, Liu Y, Hollis BW, Rimm EB: 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008, 168: 1174-1180. 10.1001/archinte.168.11.1174.CrossRefPubMedPubMedCentral
10.
go back to reference Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008, 168: 1340-1349. 10.1001/archinte.168.12.1340.CrossRefPubMed Dobnig H, Pilz S, Scharnagl H, Renner W, Seelhorst U, Wellnitz B, Kinkeldei J, Boehm BO, Weihrauch G, Maerz W: Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008, 168: 1340-1349. 10.1001/archinte.168.12.1340.CrossRefPubMed
11.
go back to reference Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC: Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009, 76: 977-983. 10.1038/ki.2009.288.CrossRefPubMedPubMedCentral Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC: Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009, 76: 977-983. 10.1038/ki.2009.288.CrossRefPubMedPubMedCentral
12.
go back to reference Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999, 55: 1019-1027. 10.1046/j.1523-1755.1999.0550031019.x.CrossRefPubMed Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int. 1999, 55: 1019-1027. 10.1046/j.1523-1755.1999.0550031019.x.CrossRefPubMed
13.
go back to reference Satirapoj B, Supasyndh O, Dispan R, Punpanich D, Tribanyatkul S, Choovichian P: Vitamin D insufficiency and deficiency in patients with advanced chronic kidney disease. Royal Thai Army Med J. 2013, 66: 9-15. Satirapoj B, Supasyndh O, Dispan R, Punpanich D, Tribanyatkul S, Choovichian P: Vitamin D insufficiency and deficiency in patients with advanced chronic kidney disease. Royal Thai Army Med J. 2013, 66: 9-15.
14.
go back to reference Stevens PE, Levin A: Kidney disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members: evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013, 158: 825-830. 10.7326/0003-4819-158-11-201306040-00007.CrossRefPubMed Stevens PE, Levin A: Kidney disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members: evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013, 158: 825-830. 10.7326/0003-4819-158-11-201306040-00007.CrossRefPubMed
15.
go back to reference Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B: Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health. 2011, 11: 853-10.1186/1471-2458-11-853.CrossRefPubMedPubMedCentral Chailurkit LO, Aekplakorn W, Ongphiphadhanakul B: Regional variation and determinants of vitamin D status in sunshine-abundant Thailand. BMC Public Health. 2011, 11: 853-10.1186/1471-2458-11-853.CrossRefPubMedPubMedCentral
16.
go back to reference Ho-Pham LT, Nguyen ND, Lai TQ, Eisman JA, Nguyen TV: Vitamin D status and parathyroid hormone in a urban population in Vietnam. Osteoporos Int. 2011, 22: 241-248. 10.1007/s00198-010-1207-4.CrossRefPubMed Ho-Pham LT, Nguyen ND, Lai TQ, Eisman JA, Nguyen TV: Vitamin D status and parathyroid hormone in a urban population in Vietnam. Osteoporos Int. 2011, 22: 241-248. 10.1007/s00198-010-1207-4.CrossRefPubMed
17.
go back to reference Nurbazlin M, Chee WS, Rokiah P, Tan AT, Chew YY, Nusaibah AR, Chan SP: Effects of sun exposure on 25(OH) vitamin D concentration in urban and rural women in Malaysia. Asia Pac J Clin Nutr. 2013, 22: 391-399.PubMed Nurbazlin M, Chee WS, Rokiah P, Tan AT, Chew YY, Nusaibah AR, Chan SP: Effects of sun exposure on 25(OH) vitamin D concentration in urban and rural women in Malaysia. Asia Pac J Clin Nutr. 2013, 22: 391-399.PubMed
18.
go back to reference LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM: Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005, 45: 1026-1033. 10.1053/j.ajkd.2005.02.029.CrossRefPubMed LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM: Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis. 2005, 45: 1026-1033. 10.1053/j.ajkd.2005.02.029.CrossRefPubMed
19.
go back to reference Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P: 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol. 2009, 20: 2631-2639. 10.1681/ASN.2009030283.CrossRefPubMedPubMedCentral Melamed ML, Astor B, Michos ED, Hostetter TH, Powe NR, Muntner P: 25-hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol. 2009, 20: 2631-2639. 10.1681/ASN.2009030283.CrossRefPubMedPubMedCentral
20.
go back to reference Isakova T, Gutierrez OM, Patel NM, Andress DL, Wolf M, Levin A: Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2011, 21: 295-302. 10.1053/j.jrn.2010.07.002.CrossRefPubMed Isakova T, Gutierrez OM, Patel NM, Andress DL, Wolf M, Levin A: Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr. 2011, 21: 295-302. 10.1053/j.jrn.2010.07.002.CrossRefPubMed
21.
go back to reference de Boer IH, Sachs MC, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD: Circulating vitamin D metabolites and kidney disease in type 1 diabetes. J Clin Endocrinol Metab. 2012, 97: 4780-4788. 10.1210/jc.2012-2852.CrossRefPubMedPubMedCentral de Boer IH, Sachs MC, Cleary PA, Hoofnagle AN, Lachin JM, Molitch ME, Steffes MW, Sun W, Zinman B, Brunzell JD: Circulating vitamin D metabolites and kidney disease in type 1 diabetes. J Clin Endocrinol Metab. 2012, 97: 4780-4788. 10.1210/jc.2012-2852.CrossRefPubMedPubMedCentral
22.
go back to reference Tonelli M: Vitamin D in patients with chronic kidney disease: nothing new under the sun. Ann Intern Med. 2007, 147: 880-881. 10.7326/0003-4819-147-12-200712180-00009.CrossRefPubMed Tonelli M: Vitamin D in patients with chronic kidney disease: nothing new under the sun. Ann Intern Med. 2007, 147: 880-881. 10.7326/0003-4819-147-12-200712180-00009.CrossRefPubMed
23.
go back to reference Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R: Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol. 1995, 9: 278-281. 10.1007/BF02254183.CrossRefPubMed Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R: Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol. 1995, 9: 278-281. 10.1007/BF02254183.CrossRefPubMed
24.
go back to reference Jacoby DS, Rader DJ: Renin-angiotensin system and atherothrombotic disease: from genes to treatment. Arch Intern Med. 2003, 163: 1155-1164. 10.1001/archinte.163.10.1155.CrossRefPubMed Jacoby DS, Rader DJ: Renin-angiotensin system and atherothrombotic disease: from genes to treatment. Arch Intern Med. 2003, 163: 1155-1164. 10.1001/archinte.163.10.1155.CrossRefPubMed
25.
go back to reference Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002, 110: 229-238.CrossRefPubMedPubMedCentral Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002, 110: 229-238.CrossRefPubMedPubMedCentral
26.
go back to reference Li YC: Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003, 88: 327-331. 10.1002/jcb.10343.CrossRefPubMed Li YC: Vitamin D regulation of the renin-angiotensin system. J Cell Biochem. 2003, 88: 327-331. 10.1002/jcb.10343.CrossRefPubMed
27.
go back to reference Agarwal R: Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol. 2009, 4: 1523-1528. 10.2215/CJN.02010309.CrossRefPubMed Agarwal R: Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Clin J Am Soc Nephrol. 2009, 4: 1523-1528. 10.2215/CJN.02010309.CrossRefPubMed
28.
go back to reference Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E: Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 1998, 53: 1696-1705. 10.1046/j.1523-1755.1998.00951.x.CrossRefPubMed Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E: Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int. 1998, 53: 1696-1705. 10.1046/j.1523-1755.1998.00951.x.CrossRefPubMed
Metadata
Title
Vitamin D insufficiency and deficiency with stages of chronic kidney disease in an Asian population
Authors
Bancha Satirapoj
Pokkrong Limwannata
Amnart Chaiprasert
Ouppatham Supasyndh
Panbuppa Choovichian
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-206

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.